Table 2 Characteristics of Physicians and Their Practices by Specialty
From: Physician preferences for non-metastatic castration-resistant prostate cancer treatment
Variable | All Physicians (N = 149) | Urologists (N = 75) | Oncologists (N = 74) | P value |
|---|---|---|---|---|
Age, years | ||||
Mean (SD) | 51.27 (10.68) | 53.91 (11.27) | 48.59 (9.39) | 0.004 |
Gender, n (%)a | ||||
Female | 15 (10.1) | 3 (4.0) | 12 (16.2) | 0.007 |
Male | 132 (88.6) | 72 (96.0) | 60 (81.1) | |
Race, n (%)a | ||||
White | 100 (67.1) | 54 (72.0) | 46 (62.2) | 0.474 |
Black | 1 (0.7) | 0 (0.0) | 1 (1.4) | |
Asian | 33 (22.1) | 13 (17.3) | 20 (27.0) | |
Middle Eastern or North African | 3 (2.0) | 2 (2.7) | 1 (1.4) | |
Native Hawaiian or Other Pacific Islander | 1 (0.7) | 0 (0.0) | 1 (1.4) | |
Ethnicity, n (%)a | ||||
Hispanic | 7 (4.7) | 1 (1.3) | 6 (8.1) | 0.175 |
Not Hispanic | 133 (89.3) | 69 (92.0) | 64 (86.5) | |
Years in practice | ||||
Mean (SD) | 17.87 (8.45) | 19.52 (8.84) | 16.20 (7.75) | 0.025 |
Median (Q1 to Q3) | 16.0 (11.0 to 25.0) | 19.0 (13.0 to 26.0) | 15.0 (10.0 to 21.0) | |
Practice type, n (%) | ||||
Office-based private practice | 103 (69.1) | 55 (73.3) | 48 (64.9) | 0.291 |
Hospital-based private practice | 18 (12.1) | 6 (8.0) | 12 (16.2) | |
Academic hospital-based | 28 (18.8) | 14 (18.7) | 14 (18.9) | |
No. of nmCRPC patients seen/physician/month | ||||
Mean (SD) | 26.21 (32.17) | 24.08 (29.21) | 28.38 (34.98) | 0.102 |
Median (Q1 to Q3) | 15.0 (5.0 to 30.0) | 12.0 (5.0 to 30.0) | 20.0 (6.0 to 35.0) | |
Most frequent medications prescribed to treat nmCRPC, n (%)b | ||||
Enzalutamide | 105 (70.5) | 56 (74.7) | 49 (66.2) | 0.258 |
Leuprolide | 100 (67.1) | 61 (81.3) | 39 (52.7) | < 0.001 |
Bicalutamide | 70 (47.0) | 38 (50.7) | 32 (43.2) | 0.364 |
Abiraterone | 62 (41.6) | 23 (30.7) | 39 (52.7) | 0.006 |
Apalutamide | 49 (32.9) | 28 (37.3) | 21 (28.4) | 0.245 |
Goserelin | 18 (12.1) | 3 (4.0) | 15 (20.3) | 0.002 |
Flutamide | 15 (10.1) | 3 (4.0) | 12 (16.2) | 0.015 |
Nilutamide | 10 (6.7) | 0 (0.0) | 10 (13.5) | < 0.001 |
Triptorelin | 6 (4.0) | 3 (4.0) | 3 (4.1) | > 0.999 |
Ketoconazole | 3 (2.0) | 2 (2.7) | 1 (1.4) | > 0.999 |
Histrelin | 1 (0.7) | 1 (1.3) | 0 (0.0) | > 0.999 |
Others | 5 (3.4) | 4 (5.3) | 1 (1.4) | 0.367 |